Reflux after intravitreal injection of bevacizumab

Ophthalmology. 2008 Jul;115(7):1270; author reply 1271. doi: 10.1016/j.ophtha.2008.02.021.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angiogenesis Inhibitors / administration & dosage*
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Female
  • Humans
  • Injections
  • Male
  • Middle Aged
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vitreous Body / drug effects

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab